Welcome to InfiCure Bio
InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.
Based on a panel of in vivo models for these conditions including a proprietary model, the NIF mouse, for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.
Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.
News
InfiCures attended with poster at the EASL NAFLD summit Sept 15-17!
InfiCure attended the EASL NAFLD summit digitally, please take the opportunity to read our poster "Effects of high fat diet on development of NASH in the NIF mouse model". The poster can be found here.
Check out InfiCures poster from the EASL 2022 meeting!
InfiCure Bio presented the poster "NKT cells promote both type 1 and type 2 inflammatory responses in the non-obese diabetic inflammation and fibrosis (NIF) mouse model". You will find the poster here.
Visit InfiCure Poster at EASL in June 22-26!
InfiCure Bio will attend the yearly EASL meeting with a poster, please take the opportunity to check out poster #FRI-154 "NKT cells promote both type 1 and type 2 inflammatory responses in the non-obese diabetic [...]
InfiCure Bio at Umeå Life Science Job Fair!
Today on May 3rd, Umeå Biotech Incubator (UBI) organized the first Umeå Life Science Job Fair. We at InfiCure Bio were happy to get the opportunity to present our business to life science students and [...]